Mesoblast
MESO
$6.07
Share price
-2.41%
Change (1 day)
80.65%
Change (1 year)
Categories
Mesoblast (MESO) - P/B ratio
P/B ratio as of April 2024 : 1.41
According to Mesoblast
's latest financial reports the company has a price-to-book ratio of 1.41.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Mesoblast - P/B ratio (from 2012 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.3762 | -56.99% |
| 2022-12-31 | 0.8747 | -29.21% |
| 2021-12-31 | 1.24 | -36.94% |
| 2020-12-31 | 1.96 | 25.55% |
| 2019-12-31 | 1.56 | 101.43% |
| 2018-12-31 | 0.7748 | -16.68% |
| 2017-12-31 | 0.9300 | 21.37% |
| 2016-12-31 | 0.7662 | -26.26% |
| 2015-12-31 | 1.04 | -47.81% |
| 2014-12-31 | 1.99 | -22.29% |
| 2013-12-31 | 2.56 | |
| 2012-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -6.34 | -548.74% | Bahamas |
 NRC Health
NRC | 16.7 | 1,081.94% | 🇺🇸 USA |